Strategic Growth Scilife has secured growth investment from Five Elms Capital in June 2024 and is expanding its market presence and adoption of the eQMS platform, signaling readiness for partner-driven sales opportunities and larger enterprise deals.

Global Remote With a 100% remote, globally distributed team, Scilife operates across multiple regions, indicating flexibility for multi-region implementations and support packages, as well as the potential for channel collaborations in different markets.

Quality Transformation The Smart Quality platform combines quality management, data analytics, augmented learning, and gamification to turn quality into a competitive advantage, creating opportunities to upsell analytics, training, and adoption services to life sciences clients.

Life Sciences Focus Existing marquee customers and partnerships in life sciences (Novartis, Biocartis, Polpharma, Pendulum, etc.) highlight readiness for expansion via additional modules like risk assessment, compliance, and end-to-end QMS enhancements across regulated environments.

Cost & Speed Customers report significant efficiency gains and reduced total cost of quality by up to 50% and faster time-to-market by up to 30%, creating a compelling value proposition for ROI-focused procurement teams and potential upsell to larger deployments.